97 related articles for article (PubMed ID: 2420870)
1. Hapten-specific, class II-restricted killing by cloned T cells: direct lysis and production of a cytotoxic factor.
Chang JC; Moorhead JW
J Immunol; 1986 Apr; 136(8):2826-31. PubMed ID: 2420870
[TBL] [Abstract][Full Text] [Related]
2. Protein-antigen specific Ia-restricted cytolytic T cells: analysis of frequency, target cell susceptibility, and mechanism of cytolysis.
Tite JP; Powell MB; Ruddle NH
J Immunol; 1985 Jul; 135(1):25-33. PubMed ID: 2582034
[TBL] [Abstract][Full Text] [Related]
3. CD4+ T cell-mediated killing of MHC class II-positive antigen-presenting cells. I. Characterization of target cell recognition by in vivo or in vitro activated CD4+ killer T cells.
Erb P; Grogg D; Troxler M; Kennedy M; Fluri M
J Immunol; 1990 Feb; 144(3):790-5. PubMed ID: 1967273
[TBL] [Abstract][Full Text] [Related]
4. Major histocompatibility complex class II-restricted cytotoxicity by self-myelin basic protein-reactive T-cell hybridomas: evidence for a tumour necrosis factor-independent nucleolytic mechanism.
Rayner DC; Petrycky-Cox LD; Diocee M; Rector E
Immunology; 1993 Feb; 78(2):273-8. PubMed ID: 7682537
[TBL] [Abstract][Full Text] [Related]
5. Cytolytic activity of antigen-specific T cells with helper phenotype.
Nakamura M; Ross DT; Briner TJ; Gefter ML
J Immunol; 1986 Jan; 136(1):44-7. PubMed ID: 2415627
[TBL] [Abstract][Full Text] [Related]
6. Anti-tumor activity of class II MHC antigen-restricted cloned autoreactive T cells. I. Destruction of B16 melanoma cells mediated by bystander cytolysis in vitro.
Shiohara T; Ruddle NH; Horowitz M; Moellmann GE; Lerner AB
J Immunol; 1987 Mar; 138(6):1971-8. PubMed ID: 3102609
[TBL] [Abstract][Full Text] [Related]
7. Epidermal cells as accessory cells in the generation of allo-reactive and hapten-specific cytotoxic T lymphocyte (CTL) responses.
Steiner G; Wolff K; Pehamberger H; Stingl G
J Immunol; 1985 Feb; 134(2):736-41. PubMed ID: 2578162
[TBL] [Abstract][Full Text] [Related]
8. Requirement for recognition of class II molecules and processed tumor antigen for optimal generation of syngeneic tumor-specific class I-restricted CTL.
Kern DE; Klarnet JP; Jensen MC; Greenberg PD
J Immunol; 1986 Jun; 136(11):4303-10. PubMed ID: 2422280
[TBL] [Abstract][Full Text] [Related]
9. Production of T-T hybrids from T cell clones. Direct comparison between cloned T cells and T hybridoma cells derived from them.
Ozaki S; Durum SK; Muegge K; York-Jolley J; Berzofsky JA
J Immunol; 1988 Jul; 141(1):71-8. PubMed ID: 2454265
[TBL] [Abstract][Full Text] [Related]
10. The requirements for triggering of lysis by cytolytic T lymphocyte clones. II. Cyclosporin A inhibits TCR-mediated exocytosis by only selectively inhibits TCR-mediated lytic activity by cloned CTL.
Lancki DW; Kaper BP; Fitch FW
J Immunol; 1989 Jan; 142(2):416-24. PubMed ID: 2492047
[TBL] [Abstract][Full Text] [Related]
11. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
Yasukawa M; Zarling JM
J Immunol; 1984 Jul; 133(1):422-7. PubMed ID: 6609990
[TBL] [Abstract][Full Text] [Related]
12. Suppressor T cell circuits in contact sensitivity. II. Induction and characterization of an efferent-acting, antigen-specific, H-2-restricted, monoclonal T cell hybrid-derived suppressor factor specific for DNFB contact hypersensitivity.
Miller SD
J Immunol; 1984 Dec; 133(6):3112-20. PubMed ID: 6208271
[TBL] [Abstract][Full Text] [Related]
13. The interaction of nominal antigen with T cell antigen receptors. I. Specific binding of multivalent nominal antigen to cytolytic T cell clones.
Siliciano RF; Keegan AD; Dintzis RZ; Dintzis HM; Shin HS
J Immunol; 1985 Aug; 135(2):906-14. PubMed ID: 2409158
[TBL] [Abstract][Full Text] [Related]
14. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM
J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053
[TBL] [Abstract][Full Text] [Related]
15. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
Sensi M; Orosz CG; Bach FH
J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
[TBL] [Abstract][Full Text] [Related]
16. Arsonate-specific murine T cell clones. V. Antigen presentation by L cells transfected with normal and mutant class II genes.
Norton FL; Davis CB; Jones PP; Goodman JW
J Immunol; 1989 Jul; 143(2):446-51. PubMed ID: 2472438
[TBL] [Abstract][Full Text] [Related]
17. Resistance of primary CD8+ cytotoxic T lymphocytes to lysis by cytotoxic granules from cloned T cell lines.
Nagler-Anderson C; Verret CR; Firmenich AA; Berne M; Eisen HN
J Immunol; 1988 Nov; 141(10):3299-305. PubMed ID: 2972770
[TBL] [Abstract][Full Text] [Related]
18. In vivo treatment with monoclonal anti-I-A antibodies: disappearance of splenic antigen-presenting cell function concomitant with modulation of splenic cell surface I-A and I-E antigens.
Kruisbeek AM; Titus JA; Stephany DA; Gause BL; Longo DL
J Immunol; 1985 Jun; 134(6):3605-14. PubMed ID: 2580891
[TBL] [Abstract][Full Text] [Related]
19. Features of target cell lysis by class I and class II MHC-restricted cytolytic T lymphocytes.
Maimone MM; Morrison LA; Braciale VL; Braciale TJ
J Immunol; 1986 Dec; 137(11):3639-43. PubMed ID: 3491143
[TBL] [Abstract][Full Text] [Related]
20. Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity.
Stalder T; Hahn S; Erb P
J Immunol; 1994 Feb; 152(3):1127-33. PubMed ID: 7507960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
